vs
Side-by-side financial comparison of Guardforce AI Co., Ltd. (GFAI) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.
Guardforce AI Co., Ltd. is the larger business by last-quarter revenue ($18.0M vs $13.8M, roughly 1.3× Gossamer Bio, Inc.). Guardforce AI Co., Ltd. runs the higher net margin — -76.9% vs -342.3%, a 265.4% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 6.3%).
Guardforce AI Co., Ltd. is a global provider of AI-integrated security solutions. Its core offerings include intelligent surveillance systems, AI-powered access control, autonomous security robots, and smart logistics monitoring services, serving enterprise, retail, financial and public sector clients across Asia, Europe and North America.
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
GFAI vs GOSS — Head-to-Head
Income Statement — Q2 FY2023 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.0M | $13.8M |
| Net Profit | $-13.8M | $-47.2M |
| Gross Margin | 12.0% | — |
| Operating Margin | -66.1% | -333.6% |
| Net Margin | -76.9% | -342.3% |
| Revenue YoY | 6.3% | 47.1% |
| Net Profit YoY | -118.5% | -43.0% |
| EPS (diluted) | $-4.35 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.8M | ||
| Q3 25 | — | $13.3M | ||
| Q2 24 | — | $95.8M | ||
| Q1 24 | — | $0 | ||
| Q3 23 | — | $0 | ||
| Q2 23 | $18.0M | $0 | ||
| Q2 22 | $16.9M | — |
| Q4 25 | — | $-47.2M | ||
| Q3 25 | — | $-48.2M | ||
| Q2 24 | — | $49.2M | ||
| Q1 24 | — | $-41.9M | ||
| Q3 23 | — | $-40.0M | ||
| Q2 23 | $-13.8M | $-42.5M | ||
| Q2 22 | $-6.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 12.0% | — | ||
| Q2 22 | 11.5% | — |
| Q4 25 | — | -333.6% | ||
| Q3 25 | — | -369.4% | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -66.1% | — | ||
| Q2 22 | -32.8% | — |
| Q4 25 | — | -342.3% | ||
| Q3 25 | — | -362.7% | ||
| Q2 24 | — | 51.4% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -76.9% | — | ||
| Q2 22 | -37.4% | — |
| Q4 25 | — | $-0.21 | ||
| Q3 25 | — | $-0.21 | ||
| Q2 24 | — | $0.22 | ||
| Q1 24 | — | $-0.19 | ||
| Q3 23 | — | $-0.21 | ||
| Q2 23 | $-4.35 | $-0.45 | ||
| Q2 22 | $-7.16 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.7M | $136.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.0M | $-122.8M |
| Total Assets | $64.1M | $172.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $136.9M | ||
| Q3 25 | — | $180.2M | ||
| Q2 24 | — | $354.5M | ||
| Q1 24 | — | $244.4M | ||
| Q3 23 | — | $328.9M | ||
| Q2 23 | $24.7M | $162.1M | ||
| Q2 22 | $7.7M | — |
| Q4 25 | — | $-122.8M | ||
| Q3 25 | — | $-82.3M | ||
| Q2 24 | — | $81.5M | ||
| Q1 24 | — | $26.7M | ||
| Q3 23 | — | $104.6M | ||
| Q2 23 | $25.0M | $-62.8M | ||
| Q2 22 | $29.4M | — |
| Q4 25 | — | $172.2M | ||
| Q3 25 | — | $208.8M | ||
| Q2 24 | — | $373.4M | ||
| Q1 24 | — | $259.4M | ||
| Q3 23 | — | $347.9M | ||
| Q2 23 | $64.1M | $181.7M | ||
| Q2 22 | $68.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $-48.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-48.3M | ||
| Q3 25 | — | $-36.2M | ||
| Q2 24 | — | $116.3M | ||
| Q1 24 | — | $-52.3M | ||
| Q3 23 | — | $-34.5M | ||
| Q2 23 | $-1.0M | $-38.3M | ||
| Q2 22 | $-13.8M | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 24 | — | 2.36× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
